|
William J. Murphy, Ph.D., is a Professor in the Microbiology and Immunology department at the University of Nevada School of Medicine in Reno. His research is focused on examining means to improve the efficacy of bone marrow transplantation (BMT) in cancer and other diseases. In addition, his laboratory has been examining BMT as a means to understand the immune system and the process of aging as well as on improving immune resistance to opportunistic infections that can arise after a transplant. Dr. Murphy is also the Director of Basic Research of the newly established Nevada Cancer Institute in Las Vegas and is a Guest Researcher at the National Cancer Institute, where he also maintains a laboratory.
Dr. Murphy earned his B.S. in Biology at Rutgers University followed by his Ph.D. in Immunology from the University of Texas Southwestern Medical School in 1989. He did a post-doctoral fellowship under Dr. Dan Longo, then Director of the Biological Response Modifiers Program at the National Cancer Institute (NCI) at Frederick. He became Principal Investigator and Section Head of the Transplantation Biology Laboratory in 1996. In 2000, he became Director of Basic Research of SAIC Frederick at the NCI with a directorate consisting of over 250 scientific personnel and an operating budget of over 30 million dollars. In 2002, Dr. Murphy joined the University of Nevada. He was awarded the American Cancer Society Scholar Award for his research on immunotherapy and BMT in 2002. He currently serves on the editorial boards for Blood, Experimental Hematology, Clinical Immunology, and Biology of Blood and Bone Marrow Transplantation. He also is an ad-hoc member of several study sections at NIH. He is Honorary Scientific Director of the Shandong Cancer Biotherapy Center in P.R. China as well as Honorary Research Professor at the Institute of Biomedical Sciences. He has published over 160 articles in scientific journals and holds several patents concerning immunotherapy in cancer.
| 